newsfilter
← Latest News
Business Wire·

MEI Pharma Reports Third Quarter Fiscal Year 2023 Results and Operational Highlights

-- MEI Begins Fourth Fiscal Quarter with $112.0 Million in Cash -- MEI Pharma, Inc. (NASDAQ:MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today reported results for the